Help055.gif (23008 bytes)¿}§¿¯fªº
             
¥¿½T»{ª¾»PÀç¾i­¹Àøªk(1)

ª©Åv«Å¥Ü¡G ¥»³æ¤¸¬O±i¦Ñ®vªººë¤ß³Ç§@¡AÅwªï¤WºôªÌ¸ü¿ý¦Û¥Î¡A¦ý­Y­nÂà¸ü¥Zµn©Î¥Xª©¡A§¡»Ý¨ú±o±i¦Ñ®vªº¦P·N¡C

¤@¡Bºü¨¥

¿}§¿¯f¦b¥xÆWµo¥Í²v¥¿³v¦~¦a¼W¥[¡A¦b1970¡B1979¦~¹ï¥x¥_¥«¡B·s²ø¥«40·³¥H¤W©~¥Á°µ¹L²±¦æ²v½Õ¬d¡Aµ²ªG¬°5.05%»P7.10%¡C1986¦~¦b¥x¥_¥«¥H¤Î¥x¥_¿¤¡B®ç¶é¿¤¡B¹ü¤Æ¿¤¡B¶³ªL¿¤¡B¥x«n¿¤ªº¶m§ø¡A°w¹ï40·³¥H¤W©~¥Á¶i¦æ¿zÀË¡Aµ²ªGÅã¥Ü¿}§¿¯f²±¦æ²v¬°6.23%¡A¨ä¤¤¶m§ø»P¥x¥_¥«°Ï¤À§O¬°5.06%»P8.17%¡A³sÄò3¦¸½Õ¬dÅã¥Ü¡A¥x¥_¥«ªº²±¦æ²v¦³³v¦~¼W¥[ªº²{¶H¡C³o©M¬ü°êHarrisªºµo²{¤@­P¡A¬ü°êªº²±¦æ²v¥Ñ1930¦~ªº0.4%¡A¼W¥[¨ì1978¦~ªº2.4%¡F¥xÆW¦Ü¥Ø«e¬°¤î¡A¿}§¿¯f±wªÌÀ³¦b10%¤§ÃСA¨C10­Ó¤H¤§¶¡¡A´N¦³¤@­Ó¿}§¿¯f¤H¡A¯u¬O¨ì¤FÄY­«ªº¦a¨B¤F¡C±wªÌªº¤H¼Æ¬°¦ó¤@ª½¼W¥[¡H²³æÁ¿¡A´N¬O±w¯fªÌµLªk²¬Â¡¡A¦Ó·sªº±wªÌ¤Sµo¥Í¤F¡A¬Gµo¯f²v²Ö¿n¦Ó§e²{¤@ª½¼W¥[¤§ÁͶաC

§Ú­Ì¤£¸T­n°Ý¡A¥Ø«e¹ï¿}§¿¯fªvÀø¤èªk¹ï¶Ü¡Hµo¥Íªº­ì¦]§ì¨ì¤F¶Ü¡H­Y§ì¨ì¦]¡AÀ³¥i±qªv¥»¥hµÛ¤â¡A¹ï¯g¤UÃĩιw¨¾¡A«ç»ò·|Åý¿}§¿¯f±wªÌ¡A¶È¯à¥´¯Ø®q¯À¨Ó±±¨î¦å¿}¡HÂå¥Í¡BÀç¾i®v¶È¯à§i¶D±wªÌª`·N¶¼­¹¡A«Ø¥ß°·±d¶¼­¹²ßºD¡A­n¿}§¿¯f±wªÌ¾Ç²ß¡G²Ä¤@¡B¤£¦Y²¢­¹¡A²Ä¤G¡B¤£¦Y¹s­¹Åý¨­Åéµo­D¡A²Ä¤T¡B¤£¦Yªo¬µ­¹ª«Åý¯à¶q°¾°ª¡A²Ä¥|¡B¤£¯à¦h¦YÅý¦å¿}¤É°ª¡A²Ä¤­¡B¤£¯àÄȾjÅý¦å¿}¤U­°¦Ó¥ð§J¡A²Ä¤»¡B¤£¯à¨ü¶ËÅý¶Ë¤fÃø¡¦X¡A²Ä¤C¡Bª`·N¤£­n¤Þµo¤ßŦ¡B¦åºÞ¯e¯f¡A²Ä¤K¡Bª`·N¤£­n¤Þµo°ª¦åÀ£¡B¤¤­·¡A²Ä¤E¡Bª`·N¤£­n¤ÞµoµÇŦ°IºÜ¡A²Ä¤Q¡Bª`·N²´·úªºµøºô½¤¯fÅÜ¡A¡E¡E¡E¡C³oºØªvÀø»P¹w¨¾ªº¤èªk¹ï¶Ü¡H¦³ªº¬O³Q°Êªº¹w¨¾¡A¦³ªº«o¬Oª`·N¤F¡A¦ý³Ì«á±wªÌÁÙ¬O·|¦º¦b¤ßŦ¡BµÇŦ¯fªº¨Öµo¯g¤W¡C

½Ð¼È®É©ñ±ó¤W­±³o¨Ç¶Ç²Îªº«ä¦Ò¼Ò¦¡¡AÅý§Ú­Ì¨Ó¬ã¨s¤@¤U¿}§¿¯fµo¥Íªº¯u¥¿­ì¦]¡A­Yª¾¨ä¦]¡A·íµM´N¥i¹w¨¾¡A¬Æ¦Ü¤]¥i¥H¥Î¨ÓªvÀø¤Î½Õ¾i¤wµo¯fªÌªº¯gª¬¡C¨ä¹ê¿}§¿¯fªºµo¥Í¤£¥~¥G¤U¦C¼ÆºÝ¡G

(¤@)¡B¦âÓi»Ä(tryptophan)¥NÁÂ¥¢±`¡G

¶¼­¹¤¤¦Y°ª³J¥Õ½è­¹ª«¤Ó¦h¡A¬Û¹ïªº¥NÁ¦¹³J¥Õ½è¤¤Ói°ò»Äªººû¥Í¯ÀB¸s¤£¨¬¡C³Ì¥D­nªº¬O³J¥Õ½è¤¤ªº¦âÓi»Ä¦b¯Ê¥Fºû¥Í¯ÀB6ªº±¡§Î¤U¡A¤£·|§¹¥þ¥NÁ¦ӷ|§Î¦¨¤¤¶¡¥NÁª«½è---¶À§¿»Ä(Xanthurenic acid)¡A¦¹¤¤¶¡¥NÁª«½è·|«I»k¡B¯}Ãa¯ØŦªºbeta²Ó­M¡A¦Óbeta²Ó­M¬O¤Àªc¯Ø®q¯Àªº¡C­Y¦¹ª¬ªp¤@ª½¥¼¨£§ïµ½¡A«h¯ØŦbeta²Ó­M³Q§¹¥þ¯}Ãa¡A´N¤£¥i¯à¤Àªc¯Ø®q¯À¡A¦¹Ãþ¿}§¿¯f±wªÌ¦]¯ØŦ¤w³Q¯}Ãa¡A¬GºÙ¬°¯Ø®q¯À¨Ì¿à«¬¡A¤@©w­nª`®g¯Ø®q¯À¨Óºû«ù¨ä¥Í²z¾÷¯à¡C

  1. ·í°Êª«ÄY­«¯Ê¥Fºû¥Í¯ÀB6®É¡A¦å¬y¤¤ªº¶À§¿»Ä(Xanthurenic acid)§t¶q¤j¤jªº´£°ª¡A¦¹¶À§¿»Ä§Y¯}Ãa¯ØŦbeta²Ó­M¡A¦b48¤p®É¤¤¿}§¿¯f§Yµo¥Í¡C

  2. ¦pªGºû¥Í¯ÀB6¯Ê¥FÄ~Äò¤U¥h¡A«h¯ØŦbeta²Ó­M³Q¯}Ãa±o§óÄY­«¡A¨ì³Ì«á¯Ø®q¯À®Ú¥»¤£¯à¤Àªc¡C

  3. ­Y°Êª«ª½±µ¬I¥´¶À§¿»Ä¡A¥ç·|³y¦¨¯ØŦbeta²Ó­Mªº³Q¯}Ãa¡A¦Ó³y¦¨¿}§¿¯f¡A¦b¹êÅç«Ç´N¬O¥H¦¹¤èªk¨Ó»s³y¿}§¿¯f°Êª«¡A¥H«K¶i¤@¨B§@ÃĪ«¸ÕÅç¡C

(¤G)¡B¯ØŦ¤¤¯Ø®q¯À¦X¦¨§xÃø¡G

¯ØŦbeta²Ó­MµL·l¡A¦ý¯Ø®q¯À¦X¦¨¤£¨¬¡A¬GºÙ¬°«D¯Ø®q¯À¨Ì¿à«¬¡A©Î³¡¥÷¯Ø®q¯À¨Ì¿à«¬¡A¦¹¬OÀç¾i¯Ê¥F°ÝÃD©Ò¤Þ°_¡C

  1. ¦¹­ì¦]¦³³J¥Õ½èÄá¨ú¬O§_§¡¿Å¨¬°÷¡A­Y¦X¦¨¯Ø®q¯Àªº51­ÓÓi°ò»Ä¨ÑÀ³µL¯Ê¡A¦A¨Ó±NÓi°ò»Ä¦X¦¨¬°¯Ø®q¯ÀªºÀç¾i¯À¬O§_¨¬°÷¡A­YµL¯Ê¥F¡A¯Ø®q¯À¦ÛµM¯à¶¶§Q¦X¦¨¡C³J¥Õ½è¤À¸Ñ¦¨Ói°ò»Ä«á¡A»Ý¦³¨¬°÷ªººû¥Í¯ÀC¡A©l¯à¶¶§Q¦X¦¨¯Ø®q¯À¡C

  2. ­Y¦X¦¨¯Ø®q¯ÀªºÓi°ò»Ä¨¬°÷¡A¨º¯A¤Î³J¥Õ½è¦X¦¨ªººû¥Í¯ÀB¸s­n¨¬°÷¡A¤×¨ä¬Oªx»Ä¡B¸­»Ä¡Bºû¥Í¯ÀB6¡BB12µ¥¡C¥H¤p¹«°µ¸ÕÅç¡A­Y¯Ê¥F¦¹µ¥ºû¥Í¯À¡A¯Ø®q¯À¤]¬O¤@ºØ³J¥Õ½è¡A¨ä¦X¦¨¥ç·|¨ü¼vÅT¡A¬G¦å²G¤¤¯Ø®q¯À·|¤£¨¬©Î¯Ê¥F¡C¥t¥~¯Ø®q¯À¦b¦X¦¨®É¡A¥ç»Ý­nÄqª«½è¦p¾N¡B»Ìµ¥¡A­Y¯Ê¥F¦¹µ¥Äqª«½è¡A¯Ø®q¯Àªº¦X¦¨¥ç¦³°ÝÃD¡C

  3. ¿}§¿¯f¤H­n¦ÛÅé¦ÛµM²£¥Í¯Ø®q¯À®É¡Aµ¹»Pºû¥Í¯ÀC»Pºû¥Í¯ÀB1¡Aªx»Ä¤Î¤j¶qªº³J¥Õ½è¡A¨Ã¥H¤Ö¦Y¦hÀ\¡A¥B­¹ª«¤¤§t¸û¤ÖªºÁÞÃþ­¹ª«(ºÒ¤ô¤Æ¦Xª«)¡A¦p¦¹¡A§Y¥i¦ÛµM¦a¥ÑÅ餺²£¥Í¨¬°÷ªº¯Ø®q¯À¡C

(¤T)¡B¯Ø®q¯À§@¥Î¥\¯à»Ùê¡G

  1. ¤@¯ë¦Ó¨¥¡A¥iÊ^ªQ(cortisone)¥i¨ë¿E¯Ø®q¯Àªº¤Àªc¡A­Y¥´¤F¥iÊ^ªQ«á¡A¦å¬y¤¤ªº¯Ø®q¯ÀÀ³·|¼W°ª¡A¦ý¦bºû¥Í¯ÀB1¡BB12¡Bªx»Äµ¥ºû¥Í¯À¯Ê¥F¤U¡A¦å¬y¤¤ªº¯Ø®q¯À«o¤£¨£±o¼W°ª¡C

  2. ¿}§¿¯f±wªÌ­Y¥þ¤£ª`®g¯Ø®q¯À¡A¦Ó§ï¨C¤éÄá­¹300~600IUªººû¥Í¯ÀE¡A«h¨ä¯f±¡«o¥i¤j¤j¦aÀò±o§ïµ½¡C¦¹Åã¥Üºû¥Í¯ÀE¦³«P¶i¯Ø®q¯À¤Àªc¤§¥\¥Î¡C

  3. ¦b¿}§¿¯f±wªÌ¯Ø®q¯À¤Àªc¤£¨¬®É¡A­YÅ餺¯Ê¥F¹[¡B¶t¡BÁâ¡B¾N¡B»Ìµ¥Äqª«½è¡A¨ä¯Ø®q¯Àªº¥\¯à¥ç¤£¯àµo´§¨ì¥¿±`ªº¤ô¥­¡C

(¥|)¡B¯Ø®q¯À¤£±Ó·P¯g¡G

  1. °£¤W­z¿}§¿¯f±wªÌ¡A¦]¯Ê¥F¬Y¨Çºû¥Í¯À¤ÎÄqª«½è«á¡A¯Ø®q¯À¥\¯à¨ü»Ùê¥~¡AÁÙ¦³¤@¨Ç¬O¦]¥Í²z¤Þ°_ªº¯Ø®q¯À¤£±Ó·P¯g¡C¨Ò¦pªÎ­DªÌÅ餺Áö¦³¤Àªc¯Ø®q¯À¡A¦ý¯Ø®q¯Àªº§@¥Î«o¤£ÆF¥ú¡A¤]´N¬O¯Ø®q¯À¥\¯à¤£±Ó·P¡C

  2. ³Ì¦­´£¥XªÎ­D©M¿}§¿¯f¦³Ãö³sªº¬OJoslin¡A¥¦¦b1921¦~«ü¥XªÎ­DªÌµo¥Í¿}§¿¯fªº¦MÀI©Ê¸û°ª¡C

  3. ªÎ­D«ùÄò®É¶¡ªºªøµu¤]¬O¼vÅT¦]¯À¤§¤@¡A±q¦~»´¨ì¤¤¦~³£ªÎ­Dªº¤H¤ñ±ß´Á¤¤¦~¤~ªÎ­Dªº¤H®e©ö±o¨ì¿}§¿¯f¡C

  4. ¦b1987¦~Ohlson¦b·ç¤h°w¹ï¨k©Êªº¬ã¨s¥çµo²{¸y³ò©MÁv³òªº¤ñ²v(W/H Ratio)©M¿}§¿¯fªºµo¥Í¦³¥¿¬ÛÃö¡AÅã¥ÜÅé¯×ªÕªº¤À¥¬¤]«Ü­«­n¡AÄ«ªG«¬(¤¤¶¡ªÎ­D«¬¡A§Y¤¤¼s¨­§÷)ªºªÎ­D¤ñ±ù¤l«¬(¥½µyªÎ­D«¬¡A§YÁv³¡¡B¤j»L¸ûªÎ­D)ªºªÎ­D¸û®e©ö¦³°ª¦å¯×¡B°ª¦åÀ£¡B°ª¦å¿}»P¯Ø®q¯Àªý§Ü§@¥Î¡C

(¤­)¡BÄá­¹¹L¶qªº¬Y¨ÇÃĪ«©ÎÀç¾i¯À¤Þ°_¡G

­Y¤@­Ó¤H¬°­nªvÀø¬YºØ¯e¯f¡AÂå¥Í©Ò¨Ï¥ÎªºÃĪ«¡A­Y§ïÅܤFÅ餺Àç¾iªº¥NÁ¡A«Ü®e©ö³y¦¨¤ºÅ¦¨ü·l¦Óµo®i¥X¨ä¥¦ªº¤ò¯f¡C

  1. ­YÄá­¹BenzothiadizinesÃĪ«®É¡A¬ù¦³12%ªº¤H·|¾É­P¿}§¿¯f¡C

  2. ¥|®ñáGÔr(Alloxan)ÃĪ«¬O§¿»Äªºµ²´¹®ñ¤Æª«¡A¯à¿ï¾Ü©Ê¦a¯}Ãa¯ØÂã]²Ó­M¡A¦Ó¤Þµo¸ÕÅç©Êªº¿}§¿¯f¡A¬G¬O»s³y¿}§¿¯f°Êª«ªºÃĪ«¡C

  3. ¥H°ª¾¯¶qµÒÆP»Ä¥iªvÀø°ªÁx©T¾J¤ò¯f¡A¦ýªø¤[¦Y¤F¤@¦~«á¡A¥i¯à»¤µo¥XÃĪ«©Êªº¿}§¿¯f¡C

¥H¤W½Ñ¦]¯À§¡·|³y¦¨¿}§¿¯f¡A­Y¯à¶EÂ_¬°¦óºØ­ì¦]§Î¦¨ªº¿}§¿¯f¡A©Î¥H¹w¨¾¤Îªv¥»ªº¨¤«×¡A¨ÓÄá­¹¨¬°÷ªºÀç¾i¯À¡A¥[¤W¤@¨ÇÅý¨ü¶Ëªº¯ØŦ¥ð®§ªº¤èªk¡A¦p­­¨î¬Y¨Ç­¹ª«¡BÃĪ«¦p¦âÓi»Ä¡BµÒ¯ó»Äµ¥¡A¨Ã¥HÂ_­¹¤èªkÅý¯ØŦ¥R¤À¥ð®§¡A¥ç¦³¤H¥Î¦¹¨Ó¹F¨ìªvÀø¿}§¿¯fªº¥Øªº¡C

¤G¡B¥ýÁA¸ÑÀç¾i¥NÁ¹Lµ{

­¹ª«¸g®ø¤Æ«á¡A³Q¦å²G§l¦¬¦Ó¿é°e¨ì¨­Åé¦U­Ó²Õ´¡A¥H»s³y·s²Ó­M;©Î¬O³Q®ñ¤Æ«á¦¨¬°¼ö¶q¡A¨Ñ¦ÛÅé¨Ï¥Î¡A¨Ã¯à±Æ¥XÅ餺¤£¥Îªº¼oª«¡C´«¥y¸Ü»¡¡A¨­Å餣Â_¦a¤À¸Ñ¡B»s³yÅé²Õ´©Ò»Ý­nªº¦UºØ¦¨¤À¡A¤]¦P®É§â¨S¦³§Q¥Î»ù­Èªºª«½è±Æ¥XÅé¥~¡AµM«á¦A±qÅé¥~¸É¥Rºc¦¨Åé²Õ´ªº·s§÷®Æ¡A³oºØ´`Àôªº¹Lµ{ºÙ¬°ª«½è¥NÁ©ηs³¯¥NÁ¡A²ºÙ¬°¥NÁ¡C

(¤@)¡BÀç¾i¯Àªº¦P¤Æ»P²§¤Æ

¥NÁ§@¥Î¥i¤À¬°¦P¤Æ»P²§¤Æ§@¥Î¨âºØ¡C§Ú­Ìªº¨­ÅéùةһݭnªºÀç¾i¯À¦³³J¥Õ½è¡B¯×ªÕ¡BÁÞÃþ¡BÄqª«½è¡Bºû¥Í¯À¤Î¤ôµ¥¤»¤jÀç¾i¯À¡C«e¤TªÌ¬°¥D­nªºÀç¾i¯À¡A¦Ó«á¨âªÌ°µ¬°»²×Q¨ÓÀ°§U«e¤TªÌÀç¾i¯Àªº®ø¤Æ¤Î§l¦¬¡C³o¨ÇÀç¾i¯À¨C¤Ñ³£¥i¥H±q­¹ª«¤¤Àò±o¡A¦b­G¸z¸Ì®ø¤Æ¡B§l¦¬«á¡A¦A¥H³o¨ÇÀç¾i¯À¬°§÷®Æ¡A¨Ó»s³y·s²Ó­M¡B¸É¥R¨­Åé²Õ´ªº®ø¯Ó¡A³oºØ¹Lµ{ºÙ¬°¦P¤Æ§@¥Î¡C

³Q²Ó­M©Ò§l¦¬ªºÀç¾i¯À¸g®ñ¤Æ¥H«á¡A²£¥Í¼ö¶q¡B¤ô¥÷¡B¤G®ñ¤ÆºÒµ¥¡A¨Ã¥B¤À¸Ñ¨­Å骺¦¨¤À¡A§â¤W­z¤£¥Îªº¼oª«±Æ¥XÅé¥~ªº¹Lµ{¡AºÙ¬°²§¤Æ§@¥Î¡C

§Ú­Ìªº¨­Åé¡A¸g¹L¦P¤Æ§@¥Î¦Ó¥Íªø¡B¼W´Þ¡B´_¤¸¥HºûÅ@°·±d;¸g²§¤Æ§@¥Î©Ò²£¥Íªº¼ö¯à¨Ó«O«ùÅé·Å¡B²£¥Í¬¡°Ê¤O¡B«O«ùºë¤O¡A¨Ï¨­Åé¦U¾¹©x¯àºÉ¨ä¾³d¡C¸z¹D©Ò§l¦¬ªº¦UºØÀç¾i¯À¤Î³Q¤À¸Ñ¦Ó¦¨ªºª«½è¡A¬O¥H­ì¨Óªº«¬ºA©ÎªÌ¬O¥H¦b¨xŦÂàÅܫ᪺«¬ºA¡A¨ÑÀ³¸£³¡¡BÂßÅé¦Ù¦×¡B¤ßŦ¤Î¨­Åé¨ä¥L¦U³¡¥÷¨Ó»s³y·sªº²Ó­M¡A¥H¤Î®ñ¤Æ¤À¸Ñ¦Ó²£¥Í¼ö¶q¡C³Q§Q¥Î¹Lªº³¡¥÷´Ý´í·|Åܦ¨¤G®ñ¤ÆºÒ¡AÂÇ©I§l±Æ¥XÅé¥~;¦³ªº·|Åܦ¨§¿¯À¡B§¿»Ä¡A©Î¦¨¬°¹³¦Ù»Ä©M¦Ù»ÄÓþ¯ëªº´á¤Æ¦Xª«¡A¦Ó¥Ñ§¿¤¤±Æ¥X¡C

(¤G)¡B¥NÁ¹Lµ{ªº½Õ¸`

¥¿±`¤HªºÅ餺¥Nºk§@¥Î¡A¤@©w¬O¦b¦³³W«h¡B¦³¯´§Çªº±¡§Î¤U¡A·Ç½T¦a°õ¦æªº¡C³o¬OÂǥѯ«¸g»Ã¯À»P¿E¯À½Õ¸`¥NÁ§@¥Îªºµ²ªG¡C¤ä°tµÛ¥NÁªº¯«¸g¬O¦Û¥D¯«®|¡A¤£³Q·N§Ó¡B·N©À©Ò¥ª¥k¡C¦Û¥D¯«¸g¦³¥æ·P©M°Æ¥æ·P¨âºØ¯«¸g¨Ó¤¬¬Û¨ó½Õ¤u§@¡A¨Ò¦p¡A¥æ·P¯«¸gºò±i®É¡A¦å¿}´N·|¤É°ª;°Æ¥æ·P¯«¸gºò±i®É¡A¦å¿}´N·|­°§C¡A³o¼Ë±K¤Á¦Ó¨}¦nªº½Õ°t¡A¤~¯à°÷¨Ï¨­Åé«O«ù¥¿±`ªº¦å¿}§t¶q¡C

¥NÁ¬O¤@ºØ¤Æ¾Ç¤ÏÀ³¡A³QÅ餺»Ã¯À½Õ¸`µÛ¡A¤~¯à¾A·íªº±±¨î¦¨¤À¡A¤£­P²£¥Í¥u¦³¬Yª«³Q¤j¶q¤À¸Ñªº¤£¥­¿Åª¬ºA¡A¤]¤£·|»s³y¥X·N¥~ªºª«½è¥X¨Ó¡C¶i¤@¨B¨¥¡A¤º¤Àªc¸¢¤Àªcªº¿E¯À¤]½Õ¸`µÛ¥NÁ§@¥Î¡A¨Ò¦p¡A¯ØŦ¥i¥H¤Àªc¯Ø®q¯À¤Î¦å¿}¤É°ª¯À¡A«eªÌ¥i¥H­°§C¦å¿}¡A¦Ó«áªÌ«o¬Û¤Ï¦a¯à¤É°ª¦å¿}¡A¨âªÌ±K¤Áªº°t¦X¡A¤~¯àºû«ù¤HÅ餺¦å¿}ªº©w­È¡C

¨­Åéùتº¦UºØ¦¨¤À¡A³£¤é¥HÄ~©]ªº´`µÛ³W«ßªk«h»s³y¥X¨Ó¡A¤@¥¹¥NÁµo¥Í²§±`²{¶H¡A¨Ï»s³y¹Lµ{¯¿¶Ã¡A´N·|¾É­P¤HÅéµo¥Í¯e¯f¡C

¯Ø®q¯À¤Àªc¤£¨¬¡A¤Þ°_¥NÁ²§±`ªºª¬ºA®É¡A´N·|¨Ï¦å¿}¼W°ª¡A¸gµÇŦ­«§l¦¬¤£§¹¥þ«á¡A§Y±Æ¤J§¿¤¤¡A´NºÙ¬°¿}§¿¯f¡C¯Ø®q¯À¥i¥H«P¶iÅ餺§l¦¬³J¥Õ½è¡B¯×ªÕ¡B¿}Ãþµ¥¦UºØÀç¾i¯À¡A¬G¯Ø®q¯À¬O¥NÁ©Ҥ£¥i©Î¯Êªº¡C¦pªG¯Ø®q¯À¤£¨¬¡A¦å²G¤¤ªº¸²µå¿}´N·|¶W¹L¥¿±`¶q(°ª¦å¿})¡A§¿¸Ì¤]´N·|§t¦³¿}¤À(¿}§¿)¡A¨Ã¥B±Æ¥X¤j¶q¤ô¤À¡C¦]¯f¤H±Æ¥X¤j¶q¤ô¥÷«h·|²£¥Í¤f´÷²{¶H¡A¤j¶q¶¼¤ô«á¤S·|±Æ¥X¤j¶q§¿²G¡F¤j¶q±Æ¥X¤ô¤À¡A¤S·|±a¨««Ü¦hºû¥Í¯À¤ÎÄqª«½è¡A§ó·|³y¦¨·L¶qÀç¾i¯Àªº¯Ê¥F¡A¦p¦¹´c©Ê¦a´`ÀôµÛ¡A·íµM¯f¤H³Ì«á·|»¤µo¨ä¥Lªº¨Öµo¯g¡C

¤T¡B¯Ø®q¯Àªº¤Àªc»P¥\¯à

(¤@)¡B¯Ø®q¯À¤Àªc

¯ØŦªº¥Í²z¸Ñ­å¾Ç¥D­n¬O¥Ñ¨âºØ²Õ´©Òºc¦¨:(1)¸¢ªw(acini)¡A(2)Äõ®æ¨u¤ó¤p®q(Islets of Langerhans)¡C¸¢ªw¨ã¦³¤Àªc®ø¤Æ²G¨ì¤Q¤G«ü¸zªº¥\¯à;Äõ®æ¨u¤ó¤p®qÁöµM¨S¦³®ø¤Æ¾÷¯à¡A«o¯àª½±µ¤Àªc¯Ø®q¯À¤Î¦å¿}¤É°ª¯À¨ì¦å¬y¤¤¡C¤HÅ骺Äõ®æ¨u¤ó¤p®q¦³¨âÃþ¥D­n²Ó­M¡A§Yªüº¸ªk(alpha)²Ó­M¥H¤Î¨©¥L(beta)²Ó­M¡C¯Ø®q¯À«Y¥Ñ¨©¥L²Ó­M©Ò»s³y¡A¦Ó¦å¿}¤É°ª¯À«h¥Ñªüº¸ªk²Ó­M©Ò¤Àªc¡CÄY­«¿}§¿¯f±wªÌªº¯ØŦ¦³®É¤´¦³´Ý¾lªº¨©¥L²Ó­M¡A¤£¹L³o¨Ç²Ó­M¨ã¦³³z©úªº¥~§Î¡A¦ýµL¤ÀªcÁû²É¥i¤Àªc¯Ø®q¯À¡C

¯Ø®q¯À¬O¤@ºØ¤p³J¥Õ½è¡A¤À¤l¶q¬ù¬°5808¡A¬O¥Ñ¨â±øÓi°ò»ÄÃì¡A©¼¦¹¤§¶¡¥HÂùÁDÁä(disulfide bond)³sµ²¦Ó¦¨¡A·í³o¨â±øÓi°ò»ÄÃì¤À¶}®É¡A¯Ø®q¯À¤À¤lªº¾÷¯à°¨¤W®ø¥¢¡C¯Ø®q¯À¦bµo´§¥¦ªº§@¥Î¤§«e¡A¥²¥ý©T©w¦b²Õ´¤W¡A«Ü¥i¯à¬O»P²Ó­M½¤µ²¦X¡C¯Ø®q¯À¤§©Ò¥H¯à°÷©T©w¦b²Õ´¤W¡A¬O¦]¬°¤W­±¤@±øÓi°ò»ÄÃ쪺ÂùÁDÀô»P²Õ´ªº²¸²B®Ú§Î¦¨Ãìµ²¡C

(¤G)¡B¯Ø®q¯Àµ²ºcªº¯µ±K

­è¶}©l£]²Ó­M©Ò¦X¦¨ªºinsulin¬O¤@±ø³æÃì¡A¦b²Ó­M¤ºÅs¦±§éÅ|¦¨¾A·í¨¤«×¡A¨ÏÂù²¸Áä§Î¦¨¡A¦Ó¦¨¬°¤@­Ó¤j¤À¤l¡A¥s«e¯Ø®q¯À(Proinsulin)¡A¥¿±`ªº£]²Ó­M¤£¤Àªcproinsulin¡A¦b«D±`ªº±¡ªp¤U¡A¦p£]²Ó­Mªø¤[³Q¨ë¿E¤Àªc¡A©Îªø¤F¥Ñ£]²Ó­Mºc¦¨ªº¸~½F®É¡A¤~·|¤Àªcproinsulin¡Cproinsulin»Pinsulin¤£¦Pªº¦a¤è¬O«eªÌ¦h¤@±ø¦hÐ`Ãì¡A±NAÃì»PBÃì³s±µ°_¨Ó¡A¦¹Ãì¥sCÐ`Ãì(C peptide)¡C¥¿±`®É¡AC Ð`Ãì­n¤ô¸Ñ±¼¥H«á¡A¯Ø®q¯À¤~·|¤Àªc¥X¨Ó¡C¨S¦³C Ð`Ãì±NAÃì»PBÃì³s±µ°_¨Ó¡A´NµLªkÅs¦±¦¨¾A·íªº¨¤«×¥H§Î¦¨Âù²¸Á䪺³sµ²¡C

C Ð`Ã줣¨ãÃþ¦ü¯Ø®q¯Àªº§@¥Î¡A¥¦»P¯Ø®q¯À¤@°_¤Àªc¥X²Ó­M¥~¡CProinsulin ¬¡©Ê¤£±j¡A¦ý¬O¥Î§K¬Ì´ú©wªk©w¶q¯Ø®q¯Àªº®É­Ô¡AProinsulin»Pinsulin¥i¥H¥æ¤¬¤ÏÀ³(cross react)¡C¥¿±`ªº¯Ø®q¯À¤Àªc¦³¿à©ó¸²µå¿}ªº®ñ¤Æ¡A¥i¯à¬O»Ý­nATP(adenosine tri-phosphate)ªº¨Ñµ¹¯à¶q¡C¯Ø®q¯Àªº¤Àªc¤]»Ý­n¦³cyclic AMP(adenosine mono-phosphate)¡A³o¸ò¨ä¥L¤º¤Àªc¨t²Îªº¤Àªc¤@¼Ë¡A§¡»Ý­n¯à¶qªº¡C¦¹¥~¡A¯Ø®q¯À¥¿±`ªº¤Àªc¤]»Ý­n¶tÂ÷¤l¡B¹[Â÷¤l¡B¾N¡B»Ìµ¥Äqª«½è¡C

²{¦b¨Ó½Í½Í¯Ø®q¯Àµ²ºcªº¯µ±K¡A¯Ø®q¯À¦³A»PB¨âÃì¡A¦Ó«e¯Ø®q¯À¤S¦h¤@CÃì¡A¥Î¨ÓÅs¦±A»PB¨âÃì¡A¥H«K¨ÏA»PB¨âÃì³sµ²¡A¤w¦p«e­z¡C¨äÓi°ò»Ä±Æ¦C¦p¤U¡G

AÃì--- Gly-Ileu-Val-Glu-Gln-Cys-Cys-Thr-Ser-Ileu-Cys-Ser-Leu-Tyr-Gln-Leu-Glu-Asp-Tyr-Cys-Asnµ¥21Ð`Ãì¡C

BÃì--- Phe-Val-Asn-Gln-His-Leu-Cys-Gly-Ser-His-Leu-Val-Glu-Ala-Leu-Tyr-Leu-Val-Cys-Gly-Glu-Arg-Gly-Phe-Phe-Tyr-Thr-Pro-Lys-Thrµ¥30­ÓÐ`Ãì¡C

C Ãì---AÃìÀY(Gly)--Arg-Lys-Gln-Leu-Ser-Gly-Glu-Leu-Ala-Leu-Pro-Gln-Leu-Ser-Gly-Ala-Gly-Pro-Gly-Gly-Gly-Leu-Glu-Val-Gln-Gly-Val-Gln-Leu-Asp-Glu-Ala-Glu-Arg-Arg---(Thr)BÃ쪺§À¡CCÃì¦@¦³35­ÓÐ`Ãì¡C

¦b¦ÛµM¬É¤¤¦³24ºØÓi°ò»Ä¡A¦ýthyroxine¡Bhydroxylysine¡Bhydroxyprolineµ¥¤TºØ¤Ö¦s¦b©ó¦ÛµM¬É¡C¥t¥~¡A¯ÖÓi»Äªºcystine¬Ocysteineªº®ñ¤Æ§ÎºA¡A¨âªÌ¥i¬Ý¦¨¤@ºØ¡A¬G¦s¦b¦ÛµM¬É¤¤ªºÓi°ò»Ä¤j¬ù¦³20ºØ¡C

ªí1¤¤¦C¥X¦³18ºØ¥D­nÓi°ò»Ä¤¤¡A¥iª¾¯Ø®q¯À¤¤¥u¦³¥Ò²¸Ói»Ä(Methionine)»P¦âÓi°ò»Ä(Tryptophan)¨S¦³³Q¥Î¨ì¡A¦Ó¥Ò²¸Ói»Ä¤S¥i¥Ñ¯ÖÓi»Ä(Cys)Âà¤Æ¦Ó¨Ó¡A¬Gª¾¯Ø®q¯À¨S¥Ò²¸Ói»Ä¥çµL©Ò¿×¡A¦p¦¹¶È¦³¦âÓi»Ä¤£³Q¨Ï¥Î¦b¯Ø®q¯À¤¤¡A¬G¦âÓi»Ä­Y¥NÁ¤£¥þ¡A·|²£¥Í¶À§¿»Ä¤§¤¤¶¡¥NÁª«¦Ó¯}Ãa¯ØŦªºbeta²Ó­M¡A¨Ï¨ä¤Àªc¯Ø®q¯Àµo¥Í°ÝÃD¡A¨}¦³¥H¤]¡C(«ÝÄò)

¡@

ªí1. ¯Ø®q¯À¤§Ói°ò»Ä¦¨¤À¤ÀªRªí

Ói°ò»Ä¦WºÙ

AÃì BÃì CÃì
1. Gly 1 3 7
2. Ile+ 2 0 0
3. Val+ 1 3 2
4. Glu 2 2 4
5. Gln 2 1 4
6. Cys+ 4 2 0
7. Thr+ 1 2 0
8. Ser+ 2 1 2
9. Leu+ 2 4 6
10. Asp 1 0 1
11. Tyr+ 2 2 0
12. Asn 1 1 0
13. Phe+ 0 3 0
14. His+ 0 2 0
15. Ala 0 1 3
16. Arg+ 0 1 3
17. Pro 0 1 2
18. Lys+ 0 1 1

¦X    ­p

21 30 35

---µù¡Gªí¤¤¦³+°O¸¹ªÌ¬°¥²»ÝÓi°ò»Ä¡A·N§Y¥²¶·¥Ñ­¹ª«¤¤Àò±o¡AÅ餺¤£¯à¦Û¦æ¦X¦¨¡C


[ ºC©Ê¯f»{ÃÑ»PªvÀø ] [ °·±d±Ð«Ç ] [ ­º ­¶ ]